#BreakingNews
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® #PeanutPatch in Peanut Allergic Children Aged 4-7 Years
Read the full press release here:
dbv-technologies.com/press_releas...
#FoodAllergy #FoodAllergies #FoodAllergyResearch #PeanutAllergy
